Industry News
Medication-Assisted Treatment is on the Rise, but Can Facilities Keep Up?
As the opioid epidemic in the United States continues to
October 29, 2018 No Comments
Day: October 29, 2018
Read More »
As the opioid epidemic in the United States continues to
As the demand for medication-assisted treatment (MAT) continues to rise amidst the opioid epidemic, treatment facilities are struggling to keep up with the increasing need for services. The use of medications such as methadone, buprenorphine, and naltrexone in combination with therapy and counseling has been shown to be effective in treating opioid addiction, but not all facilities have the resources or capacity to provide these services.
Consultants specializing in addiction treatment are being called upon to help facilities navigate the complexities of implementing MAT programs. From ensuring compliance with regulations to training staff on best practices, consultants play a crucial role in supporting facilities as they expand their services to meet the growing demand for medication-assisted treatment.
As the demand for medication-assisted treatment (MAT) continues to rise amidst the opioid epidemic, treatment facilities are struggling to keep up with the increasing need for services. The use of medications such as methadone, buprenorphine, and naltrexone in combination with therapy and counseling has been shown to be effective in treating opioid addiction, but not all facilities have the resources or capacity to provide these services.
Consultants specializing in addiction treatment are being called upon to help facilities navigate the complexities of implementing MAT programs. From ensuring compliance with regulations to training staff on best practices, consultants play a crucial role in supporting facilities as they expand their services to meet the growing demand for medication-assisted treatment.